2006•Guoji yiyao weisheng daobaoRequires access

Investigation On The Usage Of The Sustained/Controlled Release Tablets Of Our Hospital

Xiaozhen Zhang

Open publisher page 0 citations

Abstract

Objective To provide the clinic reference to the better usage of the sustained/controlled release tablets via investigation of the practice in our hospital.Method Analyze the use of the following 6 kinds of medicines by selecting 3000 pieces of medical records among all the hospitalized records of our hospital during March - May2005:Theophylline Sustained-Release Tablets, Nifedipine Controlled Release Tablets,Isosorbide Mononitrate Sustained.Release Capsules,Potassium Chloride Controlled Release Tablets, Carbidopa and Levodopa Controlled Release Tablets,Ibuprofen Sustained-Release Capsules.Result The fre- quency of taking these 6 common sustained/controlled release tablets is as follows (from high to low): Theophylline Sustained-Release Tablets 19.7%;Nifedipine Controlled Released Tablets14.8%;Potassium Chlo- ride Controlled Release Tablets 10.9%;Isosorbide Mononitrate Sustained Release Capsules9.7%;Carbidopa and Levodopa Controlled Release Tablets 6.6%;Ibuprofen Sustained-Release Capsules4.8%.Conclusion Generally, in our hospital we could use the suitable sustained/controlled release tablets in the correct and proper way. But there are still some improper uses of such medicines, such as overfrequency, overdosage and breaking tablets into pieces.

About this research paper

What this paper is about

Objective To provide the clinic reference to the better usage of the sustained/controlled release tablets via investigation of the practice in our hospital.Method Analyze the use of the following 6 kinds of medicines by selecting 3000 pieces of medical records among all the hospitalized records of our hospital during March - May2005:Theophylline Sustained-Release Tablets, Nifedipine Controlled Release Tablets,Isosorbide Mononitrate Sustained.Release Capsules,Potassium Chloride Controlled Release Tablets, Carbidopa and Levodopa Controlled Release Tablets,Ibuprofen Sustained-Release Capsules.Result The fre- quency of taking these 6 common sustained/controlled release tablets is as follows (from high to low): Theophylline Sustained-Release Tablets 19.7%;Nifedipine Controlled Released Tablets14.8%;Potassium Chlo- ride Controlled Release Tablets 10.9%;Isosorbide Mononitrate Sustained Release Capsules9.7%;Carbidopa and Levodopa Controlled Release Tablets 6.6%;Ibuprofen Sustained-Release Capsules4.8%.Conclusion Generally, in our hospital we could use the suitable sustained/controlled release tablets in the correct and proper way. But there are still some improper uses of such medicines, such as overfrequency, overdosage and breaking tablets into pieces.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To provide the clinic reference to the better usage of the sustained/controlled release tablets via investigation of the practice in our hospital.Method Analyze the use of the following 6 kinds of medicines by selecting 3000 pieces of medical records among all the hospitalized records of our hospital during March - May2005:Theophylline Sustained-Release Tablets, Nifedipine Controlled Release Tablets,Isosorbide Mononitrate Sustained.Release Capsules,Potassium Chloride Controlled Release Tablets, Carbidopa and Levodopa Controlled Release Tablets,Ibuprofen Sustained-Release Capsules.Result The fre- quency of taking these 6 common sustained/controlled release tablets is as follows (from high to low): Theophylline Sustained-Release Tablets 19.7%;Nifedipine Controlled Released Tablets14.8%;Potassium Chlo- ride Controlled Release Tablets 10.9%;Isosorbide Mononitrate Sustained Release Capsules9.7%;Carbidopa and Levodopa Controlled Release Tablets 6.6%;Ibuprofen Sustained-Release Capsules4.8%.Conclusion Generally, in our hospital we could use the suitable sustained/controlled release tablets in the correct and proper way. But there are still some improper uses of such medicines, such as overfrequency, overdosage and breaking tablets into pieces.

Key concepts: Theophylline, Nifedipine, Immediate release, Controlled release, Medicine, Isosorbide mononitrate, Dosage form, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Investigation On The Usage Of The Sustained/Controlled Release Tablets Of Our Hospital — Research Paper | ScholarLens